Prof. Dr. Hans Maier
CO-FOUNDER & MANAGING PARTNER
CONTACT DETAILSBerlin Office »
Phone: +49 30 814 871 26 |
CURRICULUM VITAEProf. Dr. Hans Maier has held senior positions in both Schering AG and Bayer AG for 25 years. For almost a decade he has worked in Asia and led the subsidiary companies of Schering in Korea and later in Japan as Managing Director. Other positions include Head of Corporate Strategy and Business Development of Schering AG and President of the Global Business Unit Diagnostic Imaging in both Schering AG and Bayer AG. Among many other company assignments Hans Maier has led Schering’s global change initiative “FOCUS” and has served for more than a decade on Schering’s International Research and Development Board.
Hans Maier serves on the advisory boards of Fraunhofer Institute for Medical Image Computing and Deutsches Herzzentrum Berlin. He is a Professor of International Strategic Management at the Berlin School of Economics and Law where he teaches the course on Organizational Change and Leadership. He holds a degree in Political Science and a PhD in Economics from Freie Universität Berlin. |
|
|
RECENT CONTRIBUTIONSThoughts on the Future of Medical Imaging: An Industry Perspective. BGM Associates Working Paper, 2016
Die Zukunft der bildgebenden Medizin. Vortrag zur Festveranstaltung 20 Jahre Fraunhofer MEVIS in Bremen, September 14, 2015 Healthcare in the next ten years: Challenges and solutions. BGM Associates Healthcare Roundtable Report, 2014 Is Personalized Medicine an Attractive Business Proposition? The Example of In-Vivo Molecular Imaging. 2nd Munich Biomarker Conference, November 22-23,2012 Strategies for closing the gap between nuclear medicine and radiology. 9th Biennial Symposium of the International Society for Strategic Studies in Radiology (IS3A), Dubrovnik/Croatia, August 25-27,2011 Advanced Imaging in Dementia. Symposium Advances in Neuroradiology – Imaging in Dementia. Polish Academy of Sciences, Polish Society of Radiology and Polish Society of Neuroradiology, Kasimierz Dolny, May 20, 2011 Bedeutung der molekularen Diagnostik für ein qualitativ hochwertiges und bezahlbares Gesundheitssystem. 1. BMBF-Symposium „Medi-WING-Medizintechnik im BMBF-Förderprogramm WING“, 1.Juli 2010 Chair of the Symposium „Contributing to Personalized Medicine: Molecular Imaging – The next paradigm shift?" , World Health Summit, Berlin, Germany, October 14-18, 2009 Molecular Imaging – An Industry Perspective, Opening Speech at the European Association of Nuclear Medicine (EANM) Congress, Munich, October11, 2008 |
